Vertex Pharmaceutica
VRTX
Real-time BATS EXCHANGE - 07/17 01:36:16 pm
180.545USD
-0.37%
Prev.180.5000
Open179.8500
High182.4079
Low179.5500
Volume1 961 482
Financials
Sales 2018 2 804 M
EBIT 2018 888 M
R. net 2018 592 M
Tréso. 2018 2 564 M
Rend. 2018 -
P/E ratio 2018 80,10
P/E ratio 2019 51,80
EV / Sales 2018 15,5x
EV / Sales 2019 12,4x
Capitalization 45 997 M
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including...
Sector :
Bio Therapeutic Drugs
Calendar :
2018-07-25 Earnings Release
Trading Rating :
Investor Rating :
Latest news
09:22aVERTEX PHARMACEUTICALS : NHS makes 'final' offer to Vertex
AQ
09:22aVERTEX PHARMACEUTICALS : responds to NHS's 'final' offer
AQ
03:14aVERTEX PHARMACEUTICALS : Nonprofit accelerates stem cell-based Parkinson's therapy work
AQ
07/16VERTEX PHARMACEUTICALS : to Announce Second Quarter 2018 Financial Results on July 25
AQ
07/12VERTEX PHARMACEUTICALS : to Announce Second Quarter 2018 Financial Results on July 25
BU
07/10VERTEX PHARMACEUTICALS : NHS England no closer to Orkambi settlement
AQ
07/10VERTEX PHARMACEUTICALS : Childrens Hospital Colorado Part of Phase 3 Trial of Vertexs Potential Triple Combo CF Therapy
AQ
07/09VERTEX PHARMACEUTICALS : CEO urges May to intervene in U.K. standoff
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance192192193
Spread/Res.-5,4%-5,4%-6,0%
Spread/Supp.14%14%15%
Support159159158